NCT02966626View on ClinicalTrials.gov

A Real World Experience of Dapagliflozin in Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

223

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 30, 2017

Study Completion Date

January 31, 2018

Conditions

Type2 Diabetes

All Listed Sponsors

lead

University of Malaya

OTHER

NCT02966626 - A Real World Experience of Dapagliflozin in Type 2 Diabetes | Biotech Hunter | Biotech Hunter